Clinical Trials Browser

Has results × Prostatic Neoplasms × Lapatinib × Clear all

NCT00246753 2017-06-28

NRR

Phase 2 Completed

29 enrolled 8 charts

Prostatic Neoplasms

NCT00103194 2014-09-30

Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer

Phase 2 Completed

49 enrolled 8 charts

Prostatic Neoplasms